Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.

Date	Fund	Action	%
2023/09/22	ARKG	Buy	0.0017
2023/09/21	ARKG	Buy	0.0276
2023/09/20	ARKG	Buy	0.0569
2023/09/19	ARKG	Buy	0.0509
2023/09/18	ARKG	Buy	0.0324
2023/09/15	ARKG	Buy	0.0513
2023/09/14	ARKG	Buy	0.0165
2023/09/12	ARKG	Buy	0.0441
2023/09/11	ARKG	Buy	0.0045
2023/08/24	ARKG	Buy	0.0581
2023/08/23	ARKG	Buy	0.0023
2023/08/22	ARKG	Buy	0.0279
2023/08/21	ARKG	Buy	0.0169
2023/08/18	ARKG	Buy	0.0072
2023/08/17	ARKG	Buy	0.0163
2023/08/16	ARKG	Buy	0.0948
2023/08/15	ARKG	Buy	0.157
2023/08/14	ARKG	Buy	0.0058
2023/08/07	ARKG	Buy	0.1107
2023/08/04	ARKG	Buy	0.1313
2023/07/11	ARKG	Buy	0.0404
2023/07/05	ARKG	Buy	0.0079
2023/06/28	ARKG	Buy	0.0019
2023/06/27	ARKG	Buy	0.0293
2023/06/26	ARKG	Buy	0.0218
2023/06/23	ARKG	Buy	0.0886
2023/06/21	ARKG	Buy	0.1444
2023/05/10	ARKG	Buy	0.0424
2023/05/09	ARKG	Buy	0.0554
2023/05/08	ARKG	Buy	0.0548